GLOBAL BLOOD THERAPEUTICS Stock News

Pfizer emerges as the lead suitor for the rare-disease company.

Pfizer emerges as the lead suitor for the rare-disease company.

Pfizer is in talks to acquire Global Blood Therapeutics, which sells a treatment for sickle cell disease called Oxbryta, The Wall Street Journal reports.

Shares of Global Blood Therapeutics Inc. GBT, +48.47% jumped 9.5% in trading on Friday after The Wall Street Journal reported that Pfizer Inc. PFE, -0.49% is considering buying the company for about $

Global Blood (GBT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Pfizer Inc is in advanced talks to buy drugmaker Global Blood Therapeutics for about $5 billion, the Wall Street Journal reported on Friday, citing people familiar with the matter.

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per sh

Global Blood (GBT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session. ChemoCentryx, Inc. (NASDAQ: CCXI)

Codiak BioSciences, Inc. (CDAK) delivered earnings and revenue surprises of 61.54% and 701.52%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stoc

A buyout rumor is powering the biotech's shares higher.

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday. Onion Global Limited (NYSE: OG) gained 113.9% to $0.8556. ChemoCentryx,

A buyout rumor is powering the biotech's shares higher.

Global Blood Therapeutics, Inc. (NASDAQ: GBT) rose 19.3% to $40.47 in pre-market trading following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, cit

Gainers Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after dropping 7% on Wednesday. GreenLight Biosciences Holdings (NASDAQ: GRNA) shares rose 100.6% to $6.54 i